Area of research
Oncology · Cancer Research · graph neural network drug discovery
Research interest
Research interests include Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment, and Melanoma and MAPK Pathways.
Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling
Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
Somatic evolution following cancer treatment in normal tissue
Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
The status of tumor mutational burden and immunotherapy
<scp>WHO</scp> 2022 landscape of papillary and chromophobe renal cell carcinoma
An introduction to the <scp>WHO</scp> 5th edition 2022 classification of testicular tumours
WHO 2022 classification of penile and scrotal cancers: updates and evolution
What's new in <scp>WHO</scp> fifth edition – urinary tract
Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab
Pervasive chromosomal instability and karyotype order in tumour evolution
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis
Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma
Resolving genetic heterogeneity in cancer
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection
Tracking the Evolution of Non–Small-Cell Lung Cancer
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma